Novo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from ...

Today, as the US Food and Drug Administration (FDA) grace period for mass compounding of "semaglutide" expires, Novo Nordisk announced a series of initiatives to further support patient access to ...

Today, as the US Food and Drug Administration (FDA) grace period for mass compounding of "semaglutide" expires, Novo Nordisk announced a series of initiatives to further support patient access to ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50 percent more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.

If you are taking Wegovy, the manufacturer offers a savings card, which may bring your insurance copay down to $0. If you do not have insurance or your insurance does not cover Wegovy, you may be able ...

A sign guiding guests into your business is more than just informative […] The post VistaPrint Has All Your Spring Printing Needs Covered With Exclusive Savings Up to $50 Off appeared first ...

The bundle will offer Novo Nordisk’s popular weight-loss drug at all its dosage strengths paired with a Hims & Hers membership providing "access to 24/7 care, ongoing clinical support, and ...

PLAINSBORO, N.J., April 29, 2025 /PRNewswire/ -- Today, Novo Nordisk announced it is expanding patient access to Wegovy ® (semaglutide) injection 2.4 mg by enabling select telehealth providers to ...

Additionally, the Wegovy ® savings offer was updated so that eligible self-paying patients can also get the $499 -per-month price at their local pharmacy.

A 2025 report from the Consumer Financial Protection Bureau says roughly 21% of consumers with a credit record were using BNPL from one of six major firms in 2022, with 20% characterized as "heavy ...